Search Results 811-820 of 16080 for ozempic

  1. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  2. Sorafenib (oral route) - Mayo Clinic

    Sorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, ...

  3. Mayo Clinic Olmsted Study of Aging (MCSA)

    This study is being done to learn more about normal memory and aging, mild memory and thinking problems, Alzheimer's disease and other forms of dementia. This ...

  4. Intensive tobacco treatment program - Doctors by specialty - Mayo Clinic

    Allied health professionals · Jennifer M. Burden, Ph.D., C.T.T.S. · Barbara Dallavalle, M.A., C.T.T.S. · Sarah E. Huiskes, M.A., L.I.C.S.W., M.S.W · Heather L.

  5. Topotecan (oral route) - Mayo Clinic

    Topotecan is used to treat small cell lung cancer that has relapsed or gotten worse. It belongs to the group of medicines known as antineoplastics or cancer ...

  6. A Study to Evaluate Effectiveness and Safety of Lenzilumab in Hospitalized Patients with COVID-19 Pneumonia (Enrolling by Invitation Only) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Infliximab-abda (intravenous route) - Mayo Clinic

    Description. Infliximab-abda injection is used in adults to treat Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, ...

  8. Captopril (oral route) - Mayo Clinic

    This can damage the blood vessels of the brain, heart, and kidneys resulting in a stroke, heart failure, or kidney failure. Lowering blood pressure can reduce ...

  9. Eelco F. Wijdicks, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Education · 1992. Fellow - Special Clinical FellowDepartment of Neurology, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine · 1989.

  10. Capivasertib (oral route) - Mayo Clinic

    Capivasertib is used in combination with fulvestrant to treat HR-positive, HER-2 negative breast cancer that is advanced or metastatic (cancer that has spread) ...